Download
s00280-020-04128-7.pdf 837,13KB
WeightNameValue
1000 Titel
  • Evaluation of patient-reported severity of hand–foot syndrome under capecitabine using a Markov modeling approach
1000 Autor/in
  1. Schmulenson, Eduard |
  2. Krolop, Linda |
  3. Simons, Sven |
  4. Ringsdorf, Susanne |
  5. Ko, Yon-Dschun |
  6. Jaehde, Ulrich |
1000 Erscheinungsjahr 2020
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2020-08-27
1000 Erschienen in
1000 Quellenangabe
  • 86(3):435-444
1000 Copyrightjahr
  • 2020
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1007/s00280-020-04128-7 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478943/ |
1000 Publikationsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Purpose!#!The inclusion of the patient's perspective has become increasingly important when reporting adverse events and may assist in management of toxicity. The relationship between drug exposure and toxicity can be quantified by combining Markov elements with pharmacometric models. A minimal continuous-time Markov model (mCTMM) was applied to patient-reported outcomes using hand-foot syndrome (HFS) induced by capecitabine anti-cancer therapy as an example.!##!Methods!#!Patient-reported HFS grades over time of 150 patients from two observational studies treated with oral capecitabine were analyzed using a mCTMM approach. Grading of HFS severity was based on the Common Terminology Criteria for Adverse Events. The model was evaluated by visual predictive checks (VPC). Furthermore, a simulation study of the probability of HFS severity over time was performed in which the standard dosing regimen and dose adjustments according to HFS severity were investigated.!##!Results!#!The VPC of the developed dose-toxicity model indicated an accurate description of HFS severity over time. Individual absolute daily dose was found to be a predictor for HFS. The simulation study demonstrated a reduction of severe HFS using the recommended dose adjustment strategy.!##!Conclusion!#!A minimal continuous-time Markov model was developed based on patient-reported severity of hand-foot syndrome under capecitabine. Thus, a modeling framework for patient-reported outcomes was created which may assist in the optimization of dosage regimens and adjustment strategies aiming at minimizing symptom burden during anti-cancer drug therapy.
1000 Sacherschließung
lokal Female [MeSH]
lokal Follow-Up Studies [MeSH]
lokal Patient-reported outcomes
lokal Aged, 80 and over [MeSH]
lokal Aged [MeSH]
lokal Adult [MeSH]
lokal Antimetabolites, Antineoplastic/adverse effects [MeSH]
lokal Humans [MeSH]
lokal Prospective Studies [MeSH]
lokal Middle Aged [MeSH]
lokal Capecitabine
lokal Hand-Foot Syndrome/etiology [MeSH]
lokal Patient Reported Outcome Measures [MeSH]
lokal Original Article
lokal Hand–foot syndrome
lokal Male [MeSH]
lokal Neoplasms/pathology [MeSH]
lokal Markov Chains [MeSH]
lokal Neoplasms/drug therapy [MeSH]
lokal Prognosis [MeSH]
lokal Hand-Foot Syndrome/pathology [MeSH]
lokal Markov model
lokal Capecitabine/adverse effects [MeSH]
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/U2NobXVsZW5zb24sIEVkdWFyZA==|https://frl.publisso.de/adhoc/uri/S3JvbG9wLCBMaW5kYQ==|https://frl.publisso.de/adhoc/uri/U2ltb25zLCBTdmVu|https://frl.publisso.de/adhoc/uri/UmluZ3Nkb3JmLCBTdXNhbm5l|https://frl.publisso.de/adhoc/uri/S28sIFlvbi1Ec2NodW4=|https://orcid.org/0000-0002-2493-7370
1000 Hinweis
  • DeepGreen-ID: 20261a765f2d4491924d2b7d80411289 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6467042.rdf
1000 Erstellt am 2023-11-17T05:58:41.854+0100
1000 Erstellt von 322
1000 beschreibt frl:6467042
1000 Zuletzt bearbeitet Fri Dec 01 05:22:28 CET 2023
1000 Objekt bearb. Fri Dec 01 05:22:28 CET 2023
1000 Vgl. frl:6467042
1000 Oai Id
  1. oai:frl.publisso.de:frl:6467042 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source